Strumento inattivo

Azioni KV Pharmaceutical Co. CL 'B' Nyse

Azioni

Prezzo di chiusura Nyse Altri mercati azionari
- ^USD	-

KV Pharmaceutical Co. CL 'B' : KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization	16/09/13
KV Pharmaceutical Co. CL 'B' : Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%) for Prescribing	24/01/13
KV Pharmaceutical Co. CL 'B' : K-V Pharmaceutical Receives Court Approval of Hologic Settlement	28/12/12
KV Pharmaceutical Co. CL 'B' : K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of Plan of Reorganization	13/12/12

Settore